Cargando…

Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand

BACKGROUND: Across the Greater Mekong Subregion, malaria remains a dangerous infectious disease, particularly for people who visit forested areas where residual transmission continues. Because vector control measures offer incomplete protection to forest goers, chemoprophylaxis has been suggested as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongdeepaisal, Monnaphat, Khonputsa, Panarasri, Prasert, Orathai, Maneenet, Suphitsara, Pongsoipetch, Kulchada, Jatapai, Anchalee, Rotejanaprasert, Chawarat, Sudathip, Prayuth, Maude, Richard J., Pell, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845363/
https://www.ncbi.nlm.nih.gov/pubmed/35164759
http://dx.doi.org/10.1186/s12936-022-04070-4
_version_ 1784651660118720512
author Jongdeepaisal, Monnaphat
Khonputsa, Panarasri
Prasert, Orathai
Maneenet, Suphitsara
Pongsoipetch, Kulchada
Jatapai, Anchalee
Rotejanaprasert, Chawarat
Sudathip, Prayuth
Maude, Richard J.
Pell, Christopher
author_facet Jongdeepaisal, Monnaphat
Khonputsa, Panarasri
Prasert, Orathai
Maneenet, Suphitsara
Pongsoipetch, Kulchada
Jatapai, Anchalee
Rotejanaprasert, Chawarat
Sudathip, Prayuth
Maude, Richard J.
Pell, Christopher
author_sort Jongdeepaisal, Monnaphat
collection PubMed
description BACKGROUND: Across the Greater Mekong Subregion, malaria remains a dangerous infectious disease, particularly for people who visit forested areas where residual transmission continues. Because vector control measures offer incomplete protection to forest goers, chemoprophylaxis has been suggested as a potential supplementary measure for malaria prevention and control. To implement prophylaxis effectively, additional information is needed to understand forest goers’ activities and their willingness to use malaria prevention measures, including prophylaxis, and how it could be delivered in communities. Drawing on in-depth interviews with forest goers and stakeholders, this article examines the potential acceptability and implementation challenges of malaria prophylaxis for forest goers in northeast Thailand. METHODS: In-depth interviews were conducted with forest goers (n = 11) and stakeholders (n = 16) including healthcare workers, community leaders, and policymakers. Interviews were audio-recorded, transcribed and coded using NVivo, employing an inductive and deductive approach, for thematic analysis. RESULTS: Forest goers were well aware of their (elevated) malaria risk and reported seeking care for malaria from local health care providers. Forest goers and community members have a close relationship with the forest but are not a homogenous group: their place and time-at-risk varied according to their activities and length of stay in the forest. Among stakeholders, the choice and cost of anti-malarial prophylactic regimen—its efficacy, length and complexity, number of tablets, potential side effects, and long-term impact on users—were key considerations for its feasibility. They also expressed concern about adherence to the preventive therapy and potential difficulty treating malaria patients with the same regimen. Prophylaxis was considered a low priority in areas with perceived accessible health system and approaching malaria elimination. CONCLUSIONS: In the context of multi-drug resistance, there are several considerations for implementing malaria prophylaxis: the need to target forest goers who are at-risk with a clear period of exposure, to ensure continued use of vector control measures and adherence to prophylactic anti-malarials, and to adopt an evidence-based approach to determine an appropriate regimen. Beyond addressing current intervention challenges and managing malaria incidence in low-transmission setting, it is crucial to keep malaria services available and accessible at the village level especially in areas home to highly mobile populations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04070-4.
format Online
Article
Text
id pubmed-8845363
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88453632022-02-16 Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand Jongdeepaisal, Monnaphat Khonputsa, Panarasri Prasert, Orathai Maneenet, Suphitsara Pongsoipetch, Kulchada Jatapai, Anchalee Rotejanaprasert, Chawarat Sudathip, Prayuth Maude, Richard J. Pell, Christopher Malar J Research BACKGROUND: Across the Greater Mekong Subregion, malaria remains a dangerous infectious disease, particularly for people who visit forested areas where residual transmission continues. Because vector control measures offer incomplete protection to forest goers, chemoprophylaxis has been suggested as a potential supplementary measure for malaria prevention and control. To implement prophylaxis effectively, additional information is needed to understand forest goers’ activities and their willingness to use malaria prevention measures, including prophylaxis, and how it could be delivered in communities. Drawing on in-depth interviews with forest goers and stakeholders, this article examines the potential acceptability and implementation challenges of malaria prophylaxis for forest goers in northeast Thailand. METHODS: In-depth interviews were conducted with forest goers (n = 11) and stakeholders (n = 16) including healthcare workers, community leaders, and policymakers. Interviews were audio-recorded, transcribed and coded using NVivo, employing an inductive and deductive approach, for thematic analysis. RESULTS: Forest goers were well aware of their (elevated) malaria risk and reported seeking care for malaria from local health care providers. Forest goers and community members have a close relationship with the forest but are not a homogenous group: their place and time-at-risk varied according to their activities and length of stay in the forest. Among stakeholders, the choice and cost of anti-malarial prophylactic regimen—its efficacy, length and complexity, number of tablets, potential side effects, and long-term impact on users—were key considerations for its feasibility. They also expressed concern about adherence to the preventive therapy and potential difficulty treating malaria patients with the same regimen. Prophylaxis was considered a low priority in areas with perceived accessible health system and approaching malaria elimination. CONCLUSIONS: In the context of multi-drug resistance, there are several considerations for implementing malaria prophylaxis: the need to target forest goers who are at-risk with a clear period of exposure, to ensure continued use of vector control measures and adherence to prophylactic anti-malarials, and to adopt an evidence-based approach to determine an appropriate regimen. Beyond addressing current intervention challenges and managing malaria incidence in low-transmission setting, it is crucial to keep malaria services available and accessible at the village level especially in areas home to highly mobile populations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04070-4. BioMed Central 2022-02-14 /pmc/articles/PMC8845363/ /pubmed/35164759 http://dx.doi.org/10.1186/s12936-022-04070-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jongdeepaisal, Monnaphat
Khonputsa, Panarasri
Prasert, Orathai
Maneenet, Suphitsara
Pongsoipetch, Kulchada
Jatapai, Anchalee
Rotejanaprasert, Chawarat
Sudathip, Prayuth
Maude, Richard J.
Pell, Christopher
Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title_full Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title_fullStr Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title_full_unstemmed Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title_short Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand
title_sort forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in thailand
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845363/
https://www.ncbi.nlm.nih.gov/pubmed/35164759
http://dx.doi.org/10.1186/s12936-022-04070-4
work_keys_str_mv AT jongdeepaisalmonnaphat forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT khonputsapanarasri forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT prasertorathai forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT maneenetsuphitsara forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT pongsoipetchkulchada forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT jatapaianchalee forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT rotejanaprasertchawarat forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT sudathipprayuth forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT mauderichardj forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand
AT pellchristopher forestmalariaandprospectsforantimalarialchemoprophylaxisamongforestgoersfindingsfromaqualitativestudyinthailand